Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2003 3
2006 7
2007 19
2008 13
2009 11
2010 6
2011 7
2012 8
2013 5
2014 17
2015 18
2016 25
2017 26
2018 35
2019 20
2020 27
2021 19
2022 16
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Results by year

Filters applied: . Clear all
Page 1
Nepafenac.
[No authors listed] [No authors listed] 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000017 Free Books & Documents. Review.
No information is available on the clinical use of nepafenac during breastfeeding. Maternal use of nepafenac eye drops would not be expected to cause any adverse effects in breastfed infants. ...
No information is available on the clinical use of nepafenac during breastfeeding. Maternal use of nepafenac eye drops would n …
Nepafenac in cataract surgery.
Bezatis A, Georgou I, Dedes J, Theodossiadis P, Chatziralli I. Bezatis A, et al. Clin Exp Optom. 2022 Apr;105(3):263-267. doi: 10.1080/08164622.2021.1945412. Epub 2021 Jul 1. Clin Exp Optom. 2022. PMID: 34210237 Free article. Review.
Topical NSAIDs have been shown to reduce postoperative ocular inflammation and pain, preserve intraoperative mydriasis, and reduce the risk of postoperative cystoid macular oedema, whilst carrying a very low side-effect profile. Nepafenac is one of the currently available …
Topical NSAIDs have been shown to reduce postoperative ocular inflammation and pain, preserve intraoperative mydriasis, and reduce the risk …
Nepafenac.
[No authors listed] [No authors listed] Aust Prescr. 2017 Dec;40(6):246-247. doi: 10.18773/austprescr.2017.071. Epub 2017 Oct 3. Aust Prescr. 2017. PMID: 29375191 Free PMC article. Review. No abstract available.
Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery.
Jones BM, Neville MW. Jones BM, et al. Ann Pharmacother. 2013 Jun;47(6):892-6. doi: 10.1345/aph.1R757. Epub 2013 May 28. Ann Pharmacother. 2013. PMID: 23715071 Review.
Three trials that compared nepafenac with other nonsteroidal antiinflammatory drugs (NSAIDs) were included. ...PGE2 concentrations were significantly lowest in the ketorolac group, followed by the bromfenac and nepafenac groups, respectively. Topical nepafenac …
Three trials that compared nepafenac with other nonsteroidal antiinflammatory drugs (NSAIDs) were included. ...PGE2 concentrations we …
Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives.
Yüksel B, Karti Ö, Kusbeci T. Yüksel B, et al. Clin Ophthalmol. 2017 Dec 11;11:2183-2190. doi: 10.2147/OPTH.S132810. eCollection 2017. Clin Ophthalmol. 2017. PMID: 29269999 Free PMC article. Review.
Topical steroids are less effective and may cause intraocular pressure increase limiting their long-term use. Nepafenac is cost effective, when the burden of PCME prevention is compared with the burden of treatment. Prevention is much cheaper and less harmful than invasive …
Topical steroids are less effective and may cause intraocular pressure increase limiting their long-term use. Nepafenac is cost effec …
Nepafenac: a unique nonsteroidal prodrug.
Lane SS. Lane SS. Int Ophthalmol Clin. 2006 Fall;46(4):13-20. doi: 10.1097/01.iio.0000212129.53019.49. Int Ophthalmol Clin. 2006. PMID: 17060788 Review. No abstract available.
Nepafenac for cystoid macular oedema secondary to paclitaxel.
Tapia Quijada HE, Quijada Fumero E, Mesa Lugo FI, Serrano García M, Betancor Caro N. Tapia Quijada HE, et al. Arch Soc Esp Oftalmol (Engl Ed). 2021 Aug;96(8):434-437. doi: 10.1016/j.oftale.2020.10.006. Epub 2021 Jul 6. Arch Soc Esp Oftalmol (Engl Ed). 2021. PMID: 34340782
As part of the study, optical coherence tomography angiography (OCTA) was performed at the time of diagnosis, and later when the symptoms subsided. Nepafenac eye drops were prescribed as treatment....
As part of the study, optical coherence tomography angiography (OCTA) was performed at the time of diagnosis, and later when the symptoms su …
An Unusual Case of Allergic Contact Dermatitis Due to Nepafenac Eye Drop.
Kumar H, Sudha S, Kumar S, A HS. Kumar H, et al. Maedica (Bucur). 2023 Jun;18(2):373-375. doi: 10.26574/maedica.2023.18.2.373. Maedica (Bucur). 2023. PMID: 37588840 Free PMC article.
Here, we present a case of 51-year-old woman who developed pruritic erythema of the eyelids after using 0.1% Nepafenac eye drops. Nepafenac is a non-steroidal anti-inflammatory drug (NSAID) commonly prescribed as eye drops for various inflammatory eye conditions. In …
Here, we present a case of 51-year-old woman who developed pruritic erythema of the eyelids after using 0.1% Nepafenac eye drops. …
Intracameral Use of Nepafenac: Safety and Efficacy Study.
Jha R, Sur V, Bhattacharjee A, Ghosh T, Kumar V, Konar A, Hazra S. Jha R, et al. Curr Eye Res. 2018 May;43(5):630-638. doi: 10.1080/02713683.2017.1408129. Epub 2017 Dec 4. Curr Eye Res. 2018. PMID: 29199864
Efficacy of nepafenac was studied by intracameral injection of 0.1%, 0.3% nepafenac, nepafenac 0.3%+1% lignocaine, and 1% lignocaine alone, before phacoemulsification surgery and intraoperative mydriasis along with PGE2(ProstaglandinE2) secretion were recorde …
Efficacy of nepafenac was studied by intracameral injection of 0.1%, 0.3% nepafenac, nepafenac 0.3%+1% lignocaine, and …
Nepafenac-associated corneal melt.
Wolf EJ, Kleiman LZ, Schrier A. Wolf EJ, et al. J Cataract Refract Surg. 2007 Nov;33(11):1974-5. doi: 10.1016/j.jcrs.2007.06.043. J Cataract Refract Surg. 2007. PMID: 17964407
The patient developed a central corneal perforation in the fellow eye while on a new NSAID formulation (nepafenac) after routine cataract surgery. Our case suggests that new topical NSAIDs may be similar to older NSAID formulations in promoting corneal melting in patients …
The patient developed a central corneal perforation in the fellow eye while on a new NSAID formulation (nepafenac) after routine cata …
261 results

Searches related to "nepafenac"